Brand-new DELHI: Medicine firm Panacea Biotec has actually introduced diabetes drug ‘Tenepan’, utilized with treating Kind 2 Diabetes Mellitus, in the country.
Tenapan strives to increase accessibility of diabetes therapy at an economical expenditure as section of the company’s dedication to the ‘Earn in India’ campaign, Panacea Biotec claimed in a regulatory filing.
“Panacea Biotec has actually constantly endeavored to companion along with clinical practitioners in helping to control their patients much better by introducing Brand-new enhanced and excellent high quality products,” Panacea Biotec Joint Controlling Supervisor Rajesh Jain said.
With the launch of Tenepan the firm intends to get to out to the patients along with the most up to date therapeutic treatment, he added.
According to the data posted last year, diabetes has actually damaged 69.1 thousand people in India and 415 thousand people worldwide.
Panacea shares were trading almost 10 each penny up at Rs 127.25 apiece regard BSE.
